Simon Galmiche Selected Research

mRNA Vaccines

2/2022	Impact of SARS-CoV-2 Delta variant on incubation, transmission settings and vaccine effectiveness: Results from a nationwide case-control study in France.
9/2021	Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Simon Galmiche Research Topics

Disease

4	COVID-19 01/2023 - 09/2021
3	Infections 01/2023 - 08/2021
2	Rheumatoid Arthritis 01/2023 - 01/2019
1	Fungemia 01/2023
1	Aspergillosis 01/2023
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2023
1	Hepatitis D 02/2022
1	Neoplasms (Cancer) 02/2022
1	Diarrhea 01/2019
1	Cutaneous Lupus Erythematosus 01/2016

Drug/Important Bio-Agent (IBA)

3	VaccinesIBA 02/2022 - 09/2021
2	mRNA VaccinesIBA 02/2022 - 09/2021
2	COVID-19 VaccinesIBA 02/2022 - 09/2021
1	AntigensIBA 01/2023
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2023
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2023
1	AntibodiesIBA 02/2022
1	Proteins (Proteins, Gene)FDA Link 02/2022
1	Messenger RNA (mRNA)IBA 09/2021
1	AA amyloidosisIBA 01/2019
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2016

Therapy/Procedure

2	Medical Day Care (Partial Hospitalization) 01/2023 - 08/2021
1	Self-Testing 01/2023